ArticleArchives of microbiology2025
Enhanced recombinant xylanase B expression in Komagataella phaffii through metabolic engineering of methanol utilization.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic engineering ofApplied and environmental microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Aspergillus niger ATCC 1015 xylanase B is an important enzyme in food industry and agricultural lignocellulose utilization. Heterologous expression of xylanase B by microbial chassis cells attracted a lot of attentions, especially Komagataella phaffii. Co-expressing enzymes involved in methanol metabolism and cofactor recycling by recombinant K. phaffii increased recombinant xylanase B expression efficiently in this study. Firstly K. phaffii formaldehyde dehydrogenase (Fld) was co-expressed to promote formaldehyde dissimilation. Furtherly, Saccharomyces cerevisiae NADH kinase Pos5 promoting NADPH production and K. phaffii 2-oxoglutarate transporter (Odc1) involving in the regeneration of mitochondrial NAD + were co-expressed to maintain the NAD + /NADH balance by converting 2-oxoglutarate to malate. The volumetric productivity and specific productivity of xylanase B were 26.22 U/(mL·h) and 8.27 U/(g·h), which were 93.2% increment of volumetric productivity and 101.8% increment of specific productivity respectively. Furtherly, increasing the utilization of methanol allows more carbon flow to the metabolic pathway, thus increasing the production of recombinant proteins. Fld, Pos5, and Odc1 co-expression enhanced methanol consumption by 10%, without retardation of specific growth rate, provided an engineered K. phaffii to express recombinant xylanase B expression significantly. In this study, the multi-enzyme co-expression strategy provided the expression level of recombinant protein increment effectively for food and agricultural industry.
Indexed as
Identifiers
40317293What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.